Avapritinib, also known as BLU-285, is a dual inhibitor of KIT receptor and platelet-derived growth factor receptor α (PDGFRα) tyrosine kinases with activating loop mutations. It is a potent, selective, and orally active medication that has demonstrated increased potency in cell lines expressing KIT and PDGFRα with activating loop mutations. Avapritinib is characterized by its high selectivity for KITD816V and PDGFRαD842V over a kinase panel at a concentration of 3 μM.
1703793-34-3
Post Buying Request-
-
Basic information
- Product Name: BLU-285
- Synonyms: BLU-285;Avapritinib;(1S)-1-(4-Fluorophenyl)-1-(2-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-1-piperazinyl}-5-pyrimidinyl)ethanamine
- CAS NO:1703793-34-3
- Molecular Formula: C26H27FN10
- Molecular Weight: 498.5579832
- EINECS: -0
- Product Categories: API
- Mol File: 1703793-34-3.mol
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: 1.42±0.1 g/cm3(Predicted)
- Refractive Index: N/A
- Storage Temp.: N/A
- Solubility: N/A
- PKA: 6.96±0.10(Predicted)
- CAS DataBase Reference: BLU-285(CAS DataBase Reference)
- NIST Chemistry Reference: BLU-285(1703793-34-3)
- EPA Substance Registry System: BLU-285(1703793-34-3)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 1703793-34-3(Hazardous Substances Data)
1703793-34-3 Suppliers
Recommended suppliers
1703793-34-3 Usage
Uses
Used in Oncology:Avapritinib is used as an anticancer agent for the treatment of tumors resulting from specific KIT and PDGFRα activating loop mutations. It has shown activity against a panel of KIT and PDGFRα loop mutants identified in patients with gastrointestinal stromal tumors (GISTs) and has demonstrated the ability to reduce tumor volume in various mouse models in a dose-dependent manner. Avapritinib is employed to inhibit the growth of cancer cell lines containing wild-type and mutant KIT and PDGFRα, particularly those with activating loop mutations, making it a promising therapeutic option for KITand PDGFRα-driven malignancies.
Check Digit Verification of cas no
The CAS Registry Mumber 1703793-34-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,7,0,3,7,9 and 3 respectively; the second part has 2 digits, 3 and 4 respectively.Calculate Digit Verification of CAS Registry Number 1703793-34:
(9*1)+(8*7)+(7*0)+(6*3)+(5*7)+(4*9)+(3*3)+(2*3)+(1*4)=173
173 % 10 = 3
So 1703793-34-3 is a valid CAS Registry Number.
1703793-34-3Upstream product
1703793-34-3Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 1703793-34-3
BLU-285
